ReviewClinical pharmacology in drug development2017

Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.

Lanfranco Pellesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.